These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 11275411

  • 1. Effects of a kappa agonist, spiradoline mesylate (U62,066E), on activation and vaginocervical-stimulation produced analgesia in rats.
    Boyle TJ, Masuda T, Cunningham ST.
    Brain Res Bull; 2001 Jan 15; 54(2):213-8. PubMed ID: 11275411
    [Abstract] [Full Text] [Related]

  • 2. A review of the properties of spiradoline: a potent and selective kappa-opioid receptor agonist.
    Wadenberg ML.
    CNS Drug Rev; 2003 Jan 15; 9(2):187-98. PubMed ID: 12847558
    [Abstract] [Full Text] [Related]

  • 3. Additive antinociceptive effects of mixtures of the κ-opioid receptor agonist spiradoline and the cannabinoid receptor agonist CP55940 in rats.
    Maguire DR, France CP.
    Behav Pharmacol; 2016 Feb 15; 27(1):69-72. PubMed ID: 26292184
    [Abstract] [Full Text] [Related]

  • 4. Intake of a palatable sucrose solution modifies the actions of spiradoline, a kappa opioid receptor agonist, on analgesia and feeding behavior in male and female rats.
    Kanarek RB, Homoleski BA, Wiatr C.
    Pharmacol Biochem Behav; 2000 Jan 01; 65(1):97-104. PubMed ID: 10638642
    [Abstract] [Full Text] [Related]

  • 5. Prevention of isolation-induced hypertension by intrahippocampal administration of a nonpeptide kappa-opioid receptor agonist.
    Wright RC, Ingenito AJ.
    Hippocampus; 2001 Jan 01; 11(4):445-51. PubMed ID: 11530849
    [Abstract] [Full Text] [Related]

  • 6. Differential effects of prenatal morphine exposure on analgesia produced by vaginocervical stimulation or systemic morphine administration in adult rats.
    Vathy I, Komisaruk BR.
    Pharmacol Biochem Behav; 2002 May 01; 72(1-2):165-70. PubMed ID: 11900784
    [Abstract] [Full Text] [Related]

  • 7. Pharmacology of opioid inhibition to noxious uterine cervical distension.
    Sandner-Kiesling A, Eisenach JC.
    Anesthesiology; 2002 Oct 01; 97(4):966-71. PubMed ID: 12357166
    [Abstract] [Full Text] [Related]

  • 8. Analgesic activity of spiradoline mesylate (U-62,066E), a kappa opioid agonist in mice.
    Kunihara M, Ohyama M, Nakano M, Hayashi S.
    Life Sci; 1989 Oct 01; 45(13):1191-8. PubMed ID: 2796604
    [Abstract] [Full Text] [Related]

  • 9. The roles of different subtypes of opioid receptors in mediating the nucleus submedius opioid-evoked antiallodynia in a neuropathic pain model of rats.
    Wang JY, Zhao M, Yuan YK, Fan GX, Jia H, Tang JS.
    Neuroscience; 2006 Oct 01; 138(4):1319-27. PubMed ID: 16472929
    [Abstract] [Full Text] [Related]

  • 10. Behavioral Characterization of κ Opioid Receptor Agonist Spiradoline and Cannabinoid Receptor Agonist CP55940 Mixtures in Rats.
    Minervini V, Dahal S, France CP.
    J Pharmacol Exp Ther; 2017 Feb 01; 360(2):280-287. PubMed ID: 27903642
    [Abstract] [Full Text] [Related]

  • 11. Kappa antinociceptive activity of spiradoline in the cold-water tail-flick assay in rats.
    Briggs SL, Rech RH, Sawyer DC.
    Pharmacol Biochem Behav; 1998 Jun 01; 60(2):467-72. PubMed ID: 9632230
    [Abstract] [Full Text] [Related]

  • 12. Analgesia is produced by uterocervical mechanostimulation in rats: roles of afferent nerves and implications for analgesia of pregnancy and parturition.
    Gintzler AR, Komisaruk BR.
    Brain Res; 1991 Dec 06; 566(1-2):299-302. PubMed ID: 1814546
    [Abstract] [Full Text] [Related]

  • 13. Kappa opioids inhibit physiologically identified medullary pain modulating neurons and reduce morphine antinociception.
    Meng ID, Johansen JP, Harasawa I, Fields HL.
    J Neurophysiol; 2005 Mar 06; 93(3):1138-44. PubMed ID: 15456805
    [Abstract] [Full Text] [Related]

  • 14. Morphine and corticotrophin-releasing factor potentiate maternal acceptance in multiparous ewes after vaginocervical stimulation.
    Keverne EB, Kendrick KM.
    Brain Res; 1991 Feb 01; 540(1-2):55-62. PubMed ID: 2054633
    [Abstract] [Full Text] [Related]

  • 15. Kappa opioid agonist-induced changes in IOP: correlation with 3H-NE release and cAMP accumulation.
    Moore TT, Potter DE.
    Exp Eye Res; 2001 Aug 01; 73(2):167-78. PubMed ID: 11446767
    [Abstract] [Full Text] [Related]

  • 16. Antinociceptive and response rate-altering effects of kappa opioid agonists, spiradoline, enadoline and U69,593, alone and in combination with opioid antagonists in squirrel monkeys.
    Pitts RC, Dykstra LA.
    J Pharmacol Exp Ther; 1994 Dec 01; 271(3):1501-8. PubMed ID: 7996463
    [Abstract] [Full Text] [Related]

  • 17. Differential effects of mu-, delta-, and kappa-opioid receptor agonists on mechanosensitive gastric vagal afferent fibers in the rat.
    Ozaki N, Sengupta JN, Gebhart GF.
    J Neurophysiol; 2000 Apr 01; 83(4):2209-16. PubMed ID: 10758129
    [Abstract] [Full Text] [Related]

  • 18. Dietary modulation of mu and kappa opioid receptor-mediated analgesia.
    Kanarek RB, Przypek J, D'Anci KE, Marks-Kaufman R.
    Pharmacol Biochem Behav; 1997 Sep 01; 58(1):43-9. PubMed ID: 9264068
    [Abstract] [Full Text] [Related]

  • 19. Age-related differences in sensitivity to the antinociceptive effects of kappa opioids in adult male rats.
    Smith MA, French AM.
    Psychopharmacology (Berl); 2002 Jul 01; 162(3):255-64. PubMed ID: 12122483
    [Abstract] [Full Text] [Related]

  • 20. Analysis of the antinociceptive actions of the kappa-opioid agonist enadoline (CI-977) in neonatal and adult rats: comparison to kappa-opioid receptor mRNA ontogeny.
    McLaughlin CR, Tao Q, Abood ME.
    Drug Alcohol Depend; 1995 Jun 01; 38(3):261-9. PubMed ID: 7555627
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.